Kemin Industries Acquires CJ Bio Subsidiary CJ Youtell Biotech
Specializing in enzymes and fermentation, the biotech company will transform the expansion of Kemin's global enzyme production capabilities
With this acquisition, Kemin has full ownership of CJ Youtell's fermentation plants and its enzyme product portfolio. CJ Youtell brings to Kemin a world-class fermentation platform, including strategically located plants in
"We are pleased to welcome CJ Youtell into the Kemin family," said Dr.
The addition of the new facilities in
"The acquisition of CJ Youtell marks a powerful expansion of Kemin's enzyme capabilities," said
This integration builds on Kemin's decades of enzyme expertise to create a seamless, end-to-end offering to customers. By combining in-house fermentation with advanced formulation, technical sales support, and Customer Laboratory Services, Kemin is uniquely positioned to deliver tailored, high-performing enzyme technologies. These expanded capabilities enhance Kemin's agility and accelerate innovation, empowering customers to stay ahead in competitive and evolving markets.
About Kemin Industries
Kemin Industries (www.kemin.com) is a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services. The company supplies over 500 specialty ingredients for human and animal health and nutrition, pet food, aquaculture, nutraceutical, food technologies, crop technologies, textile, biofuel, and animal vaccine industries.
For over half a century, Kemin has been dedicated to using applied science to address industry challenges and offer product solutions to customers in more than 120 countries. Kemin provides ingredients to feed a growing population with its commitment to the quality, safety, and efficacy of food, feed, and health-related products.
Established in 1961, Kemin is a privately held, family-owned-and-operated company with more than 3,300 global employees and operations in 90 countries, including manufacturing facilities in
Media Contact:
[email protected], (+1) 515-559-5361
© Kemin Industries, Inc. and its group of companies 2025. All rights reserved. ® TM Trademarks of Kemin Industries, Inc., U.S.A.
Certain statements, product labeling and claims may differ by geography or as required by government requirements.
View original content to download multimedia:https://www.prnewswire.com/news-releases/kemin-industries-acquires-cj-bio-subsidiary-cj-youtell-biotech-302561735.html
SOURCE Kemin Industries
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CPKC and IBEW agree to binding arbitration ending strike
- Kimbell Royalty Partners Closes $221.2 Million Drop Down Acquisition
- CoreAgeRx Launches Advanced Preventive Longevity Protocols Featuring Microdosing Semaglutide, Microdosing Tirzepatide, and Sermorelin Therapies
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share